A Comparative Double-Blind Trial of the New Antidepressant Caroxazone and Amitriptyline

@article{Cecchini1978ACD,
  title={A Comparative Double-Blind Trial of the New Antidepressant Caroxazone and Amitriptyline},
  author={S Cecchini and Petar Petri and Rita B. Ardito and Silvio R. Bareggi and A Torriti},
  journal={Journal of International Medical Research},
  year={1978},
  volume={6},
  pages={388 - 394}
}
On the grounds of pharmacological properties and preliminary clinical trials the efficacy of the new antidepressant caroxazone was compared to amitriptyline in the management of depression. Forty patients mostly suffering from a neurotic or anxious-neurotic depression were admitted to a double-blind trial. All patients completed the study. The Hamilton Rating Scale for Depression was used for the clinical assessment at the beginning, during and at the end of treatment. The trial lasted three… 

Figures and Tables from this paper

Effect of caroxazone, a new antidepressant drug, on monoamine oxidases in healthy volunteers.

It can be concluded that caroxazone is a MAO inhibitor in man too, at a clinically effective dose such as 600 mg/day, and the fact that its MAO inhibition is not apparent in platelet preparation may be explained by its reversibility.

Effects of caroxazone, a reversible monoamine oxidase inhibitor, on the pressor response to oral tyramine in man.

The reversibility of the MAO-inhibitory action of caroxazone is confirmed by the rapid return to normal values in the response to tyramine after discontinuation of treatment, which would allow patients to return to a free diet in much less time than the safety limit of 2 weeks recommended for the currently used irreversible MAO -inhibitors.

Second-Generation Antidepressants

Both groups elevate mood in individuals suffering from endogenous depression, a disorder that, up to that time, could only be effectively reversed with shock therapy, and contributed significantly to the establishment of psychopharmacology.

Effects of caroxazone, a reversible monoamine oxidase inhibitor, on the pressor response to intravenous tyramine in man.

Caroxazone seems to be safer and more manageable than all other clinically available MAO-inhibitors which produce irreversible inactivation of MAO.

Pharmacotherapy for dysthymia

The conclusion is that the choice of drug must be made based on consideration of drug-specific side effect properties, and the evidence for TCAs and SSRIs was the most robust, considering the number of trials and participants.

EFFECTS OF CAROXAZONE, A REVERSIBLE MONOAMINE

Caroxazone seems to be safer and more manageable than all other clinically available MAOinhibitors which produce irreversible inactivation of MAO.

Monoamine Oxidase Inhibitors—Revisiting a Therapeutic Principle

This review revisits monoamine oxidase inhibitors and their potential in the treatment of human diseases, such as anxiety, depression, mood and personality disorders, and pain and introduces current ideas and developments.

Elavil® (Merck Sharp & Dohme)

Amitriptyline is an antidepressant with antianxiety action and a sedative component and is known to inhibit the membrane mechanism responsible for reuptake of norepinephrine into adrenergic neurons.

Handbook of Psychopharmacology

References

SHOWING 1-10 OF 20 REFERENCES

The Private Practice Research Group (PPRG): A Working Model from Psychopharmacology for Clinical Research in Family Practice

Drug trial data obtained in hospital settings may prove of only limited value in predicting drug response in family practice, despite growing evidence that the treatment response of hospital clinic and inpatients often differs markedly from that of family practice patient.

A RATING SCALE FOR DEPRESSION

  • M. Hamilton
  • Psychology, Medicine
    Journal of neurology, neurosurgery, and psychiatry
  • 1960
The present scale has been devised for use only on patients already diagnosed as suffering from affective disorder of depressive type, used for quantifying the results of an interview, and its value depends entirely on the skill of the interviewer in eliciting the necessary information.

Studio clinico su un nuovo farmaco antidepressivo : Caroxazone ( FI 6654 )

  • Neopsichiatria
  • 1973

Contributo clinico sull'attivita timoanalettica di un nuovo farmaco antidepressivo: Caroxazone-FI 6654

  • Rivista Sperimentale di Freniatria
  • 1974